Showing 1 - 15 results of 15 for search 'Jan-Dirk Studt', query time: 0.05s
Refine Results
-
1
Coronavirus-induced coagulopathy during the course of disease. by Marie Sophie Friedrich, Jan-Dirk Studt, Julia Braun, Donat R Spahn, Alexander Kaserer
Published 2020-01-01
Article -
2
-
3
-
4
-
5
Point-of-Care Diagnostics in Coagulation Management by Sebastian D. Sahli, Julian Rössler, David W. Tscholl, Jan-Dirk Studt, Donat R. Spahn, Alexander Kaserer
Published 2020-07-01
Article -
6
Accuracy of a Single, Heparin-Calibrated Anti-Xa Assay for the Measurement of Rivaroxaban, Apixaban, and Edoxaban Drug Concentrations: A Prospective Cross-Sectional Study by Tamana Meihandoest, Tamana Meihandoest, Jan-Dirk Studt, Jan-Dirk Studt, Adriana Mendez, Lorenzo Alberio, Pierre Fontana, Walter A. Wuillemin, Adrian Schmidt, Lukas Graf, Bernhard Gerber, Bernhard Gerber, Ursula Amstutz, Cedric Bovet, Thomas C. Sauter, Lars M. Asmis, Michael Nagler
Published 2022-03-01
Article -
7
Indications and Outcomes of Patients Receiving Therapeutic Plasma Exchange under Critical Care Conditions: A Retrospective Eleven-Year Single-Center Study at a Tertiary Care Center by Alexander Ring, Wolfgang Alexander Sieber, Jan-Dirk Studt, Reto A. Schuepbach, Christoph Camille Ganter, Markus Gabriel Manz, Antonia Maria Susanne Müller, Sascha David
Published 2023-04-01
Article -
8
Challenges in Coagulation Management in Neurosurgical Diseases: A Scoping Review, Development, and Implementation of Coagulation Management Strategies by Menno R. Germans, Jonas Rohr, Christoph Globas, Tilman Schubert, Alexander Kaserer, Giovanna Brandi, Jan-Dirk Studt, Matthias Greutmann, Katharina Geiling, Lotte Verweij, Luca Regli
Published 2023-10-01
Article -
9
Prothrombinase-Induced Clotting Time to Measure Drug Concentrations of Rivaroxaban, Apixaban, and Edoxaban in Clinical Practice: A Cross-Sectional Study by Vepusha Sathanantham, Lorenzo Alberio, Cédric Bovet, Pierre Fontana, Bernhard Gerber, Lukas Graf, Adriana Mendez, Thomas C. Sauter, Adrian Schmidt, Jan-Dirk Studt, Walter A. Wuillemin, Michael Nagler
Published 2022-07-01
Article -
10
Determination of Anti-Xa Inhibitor Plasma Concentrations Using a Universal Edoxaban Calibrator by Annika Burger, Jan-Dirk Studt, Adriana Mendez, Lorenzo Alberio, Pierre Fontana, Walter A. Wuillemin, Adrian Schmidt, Lukas Graf, Bernhard Gerber, Cédric Bovet, Thomas C. Sauter, Nikolaus B. Binder, Michael Nagler
Published 2023-06-01
Article -
11
Automated Thrombin Generation Assay for Rivaroxaban, Apixaban, and Edoxaban Measurements by Tamana Meihandoest, Tamana Meihandoest, Jan-Dirk Studt, Adriana Mendez, Lorenzo Alberio, Pierre Fontana, Walter A. Wuillemin, Adrian Schmidt, Lukas Graf, Bernhard Gerber, Bernhard Gerber, Gabriela Monika Maeder, Cédric Bovet, Thomas C. Sauter, Michael Nagler, Michael Nagler
Published 2021-09-01
Article -
12
Management of bleeding events and invasive procedures in patients with haemophilia A without inhibitors treated with emicizumab by Pierre Fontana, Lorenzo Alberio, Manuela Albisetti, Anne Angelillo-Scherrer, Lars M. Asmis, Alessandro Casini, Bernhard Gerber, Lukas Graf, Inga Hegemann, Wolfgang Korte, Maria Martinez, Jan-Dirk Studt, Dimitrios A. Tsakiris, Walter A. Wuillemin, Johanna A. Kremer Hovinga
Published 2020-12-01
Article -
13
A machine-learning model for reducing misdiagnosis in heparin-induced thrombocytopenia: A prospective, multicenter, observational studyResearch in context by Henning Nilius, Adam Cuker, Sigve Haug, Christos Nakas, Jan-Dirk Studt, Dimitrios A. Tsakiris, Andreas Greinacher, Adriana Mendez, Adrian Schmidt, Walter A. Wuillemin, Bernhard Gerber, Johanna A. Kremer Hovinga, Prakash Vishnu, Lukas Graf, Alexander Kashev, Raphael Sznitman, Tamam Bakchoul, Michael Nagler
Published 2023-01-01
Article -
14
Suggestions for thromboprophylaxis and laboratory monitoring for in-hospital patients with COVID-19 by Alessandro Casini, Lorenzo Alberio, Anne Angelillo-Scherrer, Pierre Fontana, Bernhard Gerber, Lukas Graf, Inga Hegemann, Wolfang Korte, Johanna A. Kremer Hovinga, Thomas Lecompte, Maria Martinez, Michael Nagler, Jan-Dirk Studt, Dimitrios Tsakiris, Walter Wuillemin, Lars M. Asmis, Working Party on Hemostasis of the Swiss Society of Hematology
Published 2020-04-01
Article -
15
Recommendations on the use of anticoagulants for the treatment of patients with heparin-induced thrombocytopenia in Switzerland by Lorenzo A. Alberio, Anne Angelillo-Scherrer, Lars M. Asmis, Alessandro Casini, Pierre Fontana, Lukas Graf, Inga Hegemann, Johanna A. Kremer Hovinga, Wolfgang Korte, Thomas Lecompte, Martina Martinez, Michael Nagler, Jan-Dirk Studt, Dimitrios A. Tsakiris, Walter A. Wuillemin, members of the Working Party Hemostasis (WPH) of the Swiss Society of Hematology (SGH-SSH), in alphabetical order
Published 2020-04-01
Article